Neil Kerslake Gibbs

Title: Neil Kerslake Gibbs: Innovator in Skin Barrier Function

Introduction

Neil Kerslake Gibbs is a notable inventor based in Cheshire, GB. He has made significant contributions to the field of dermatology, particularly in the treatment of inflammatory skin diseases. His innovative approach focuses on enhancing the barrier function of the skin, which is crucial for maintaining overall skin health.

Latest Patents

Gibbs holds a patent for "Histidine and/or histidine derivative for the treatment of inflammatory skin diseases." This patent describes a method for maintaining and improving the barrier function of human skin. The method involves orally administering an effective amount of histidine or its derivatives to individuals in need of skin barrier maintenance or improvement. The effectiveness of this method can be assessed by measuring transepidermal water loss, with dosages ranging from about 0.5 g to about 7 g per single dose.

Career Highlights

Throughout his career, Neil Kerslake Gibbs has worked with various organizations that have contributed to his research and development efforts. Notably, he has been associated with Curapel Limited, a company based in Scotland, and The University of Manchester. His work in these institutions has allowed him to collaborate with other experts in the field and advance his innovative ideas.

Collaborations

Due to space constraints, the details of collaborations will not be included in this section.

Conclusion

Neil Kerslake Gibbs is a pioneering inventor whose work on histidine and its derivatives has the potential to transform the treatment of inflammatory skin diseases. His contributions to dermatology highlight the importance of innovation in improving health outcomes.